Integrin
All Product Categories
-
Integrin Inhibitors
(183)
View all products
-
Integrin Agonists
(5)
View all products
-
Integrin Antagonists
(67)
View all products
-
Integrin Activators
(6)
View all products
-
Integrin Modulators
(5)
View all products
-
Integrin Chemicals
(2)
View all products
-
Integrin Inducers
(2)
View all products
-
Integrin Degrader
(1)
View all products
-
Integrin Controls
(3)
View all products
-
Integrin Substrate
(1)
View all products
-
Integrin Ligands
(15)
View all products
-
Integrin Related Products (380)
Related Products (380)
-
Cyclopeptide-5
0 ImagesCat. No.: HY-A0300CAS No.: 197172-76-2Synonyms: EMD 270179Cyclopeptide-5 (EMD 270179) is an αvβ3 antagonist that can improve PAF-induced increased adhesion of sickle red blood cells, capillary post-obstruction, and enhance blood flow dynamics. Cyclopeptide-5 also has cytotoxic effects.
-
Tetrac (Standard)
0 ImagesSynonyms: Tetraiodothyroacetic acid (Standard); 3,3',5,5'-Tetraiodothyroacetic acid (Standard)Tetrac (Tetraiodothyroacetic acid), a derivative of L-thyroxine (T4), is a thyrointegrin receptor antagonist. Tetrac blocks the actions of T4 and 3,5,3'-triiodo-L-thyronine (T3) at the cell surface receptor for thyroid hormone on integrin αvβ3. Tetra has anti-angiogenic and anti-tumor activities.
-
EMD527040 hydrochloride
0 ImagesCat. No.: HY-101473AEMD527040 (hydrochloride) is a highly potent and selective αvβ6 antagonist with anti-fibrotic activity. EMD527040 (hydrochloride) is used in the research of liver cancer and liver fibrosis.
-
ATL 1102
0 ImagesCat. No.: HY-153481CAS No.: 350263-41-1Synonyms: ISIS-107248; AvicursenATL 1102 (Avicursen) is a novel second-generation antisense oligonucleotide to CD49d mRNA
-
ASD141
0 ImagesCat. No.: HY-P992314
-
BIRT2584
0 ImagesCat. No.: HY-19492CAS No.: 688756-00-5BIRT2584 is an LFA-1 inhibitor. BIRT2584 can be used for research on autoimmune diseases.
-
SAN-300
0 ImagesCat. No.: HY-P991434SAN-300 is a human IgG1 monoclonal antibody (mAb) targeting ITGA1/VLA-1. SAN-300 can be used in Rheumatoid arthritis research.
-
NOTA-IMB-RGD
0 ImagesCat. No.: HY-175323NOTA-IMB-RGD is a dual molecular probe targeting integrin αvβ3 and programmed death ligand-1 (PD-L1). NOTA-IMB-RGD blocks the PD-1/PD-L1 signaling pathway and integrin αvβ3-overexpressing tumor vasculature. NOTA-IMB-RGD is promising for research of solid tumors co-expressing PD-L1 and αvβ3 (e.g., glioma, breast cancer).
-
mP6
0 ImagesCat. No.: HY-P10038CAS No.: 2700321-79-3Synonyms: Myr-FEEERA-OH
-
L-703014
0 ImagesCat. No.: HY-117824CAS No.: 142638-79-7L-703014 is a fibrinogen receptor antagonist, with the IC50 of 94 nM, that acts as a novel parenteral and potential oral antithrombotic agent.
-
L-767685
0 ImagesCat. No.: HY-125373CAS No.: 183745-58-6L-767685, the ethyl ester prodrug of L-767679 (HY-116925), is a non-peptide glycoprotein IIb/IIIa receptor (GPIIb-IIIa receptor) antagonist. L-767679 has a potent anti-platelet aggregation effect. L-767685 can be used for research on antithrombosis.
-
BTT-3034
0 ImagesCat. No.: HY-177331CAS No.: 1259029-47-4
-
BT100 sodium
0 ImagesCat. No.: HY-153998BT100 (sodium), a aptamer, inhibits binding of von Willebrand factor (VWF) to platelet glycoprotein GPIb, preventing arterial thrombosis.
-
myr-RGT
0 ImagesCat. No.: HY-P11495CAS No.: 1126379-15-4myr-RGT is a nutmeg acylated RGT peptide. myr-RGT can be used to inhibit extracellular signaling of integrin β3. myr-RGT can be used in the research of atherosclerosis and other related conditions.
-
ανβ6 Integrin ligand-2
0 ImagesCat. No.: HY-185466CAS No.: 3047235-19-5
-
RTDLDSLRTYTL TFA
0 ImagesCat. No.: HY-P10417BRTDLDSLRTYTL TFA is an Alpha (v) beta (6) integrin (avb6) inhibitor with high affinity and specificity. RTDLDSLRTYTL TFA binds to avb6 integrin, a peptide sequence that activates cytotoxicity and cytokine production in T cells, such as interferon-gamma. RTDLDSLRTYTL TFA is designed through a chimeric T cell antigen receptor (CAR) so that T cells can be redirected to specifically recognize and attack tumor cells. RTDLDSLRTYTL TFA can be used in the research of cancer immunotherapy and targeted drug development.
-
TAK-029
0 ImagesCat. No.: HY-19229CAS No.: 176655-58-6TAK-029 is a potent GP IIb/IIIa antagonist. TAK-029 has potent antithrombotic effects with bleeding time (BT) prolongation in arterial thrombosis models. TAK-029 can be used for the research of various arterial thrombotic diseases.
